Showing 1 - 10 of 54
We examine how R&D portfolios of drug pipelines affect pharmaceutical licensing, controlling firm size, diversity, and competition. The data collected comprises 434 license-ins and 329 license-outs closed by 54 Japanese pharmaceutical companies between 1997 and 2007. We pay special attention to...
Persistent link: https://www.econbiz.de/10010785083
While most economists believe that public scientific research fuels industry innovation and economic growth, systematic evidence supporting this relationship is surprisingly limited. In a recent study, Acemoglu and Linn (2004) identified market size as a significant driver of drug innovation in...
Persistent link: https://www.econbiz.de/10010572691
We propose an empirical strategy for estimating competition in innovation markets based on a model of creative-destruction. Our method relates firms’ market return on equity to information about patent citation patterns. Two innovations we introduce are using daily abnormal stock returns...
Persistent link: https://www.econbiz.de/10014204193
When firms open up to external resources for innovation, do internal incentives still matter? This paper investigates the moderating effect of open innovation on the relationship between incentives and innovation using a survey database of British firms. Whilst both openness and incentives are...
Persistent link: https://www.econbiz.de/10010869340
We empirically address value appropriation hazards when firms enter into external relationships in search for innovation. Using firm-level data from Germany we document a positive link between R&D outsourcing and intellectual property infringement. In line with theory we show that this effect...
Persistent link: https://www.econbiz.de/10011263822
This paper investigates the impact of scientific relatedness on knowledge dynamics in biotech at the city level during the period 1989–2008. We assess the extent to which the emergence of new research topics and the disappearance of existing topics in cities are dependent on their degree of...
Persistent link: https://www.econbiz.de/10010729635
Biotechnology firms operate in a high-risk and high-reward environment and are in a constant race to secure venture capital (VC) funds. Previous contributions to the literature show that the VC firms tend to invest locally in order to monitor their investments and to provide operating assistance...
Persistent link: https://www.econbiz.de/10010572675
In recent years, firms have increasingly contributed to and been confronted with a patent landscape characterized by numerous but marginal inventions, overlapping claims and patent fences. As a result, firms risk their patent applications to be pre-empted or to be infringed upon by rivals. While...
Persistent link: https://www.econbiz.de/10010869314
This study examines why compact organizational space may matter for technological catch-up, through a comparison of China's leading automotive groups. The comparative analysis demonstrates that the Shanghai Automotive Industry Corporation (SAIC) surpasses its two local rivals in terms of...
Persistent link: https://www.econbiz.de/10011116605
Using a new dataset with detailed geographic information about licensing activities of the German Max Planck Society, we analyze how the probability and magnitude of commercial success are affected by geographic distance between licensors and licensees. Our evidence suggests that proximity does...
Persistent link: https://www.econbiz.de/10010616987